Andrew Bachman, MD
Chief Executive Officer, Board Chairman, Co-founder
When you know better, do better. These words by Maya Angelou inspire Andrew Bachman’s approach to medicine and caregiving. Because after more than a decade working as an emergency medicine doctor, Bachman saw firsthand the shortcomings of available pharmaceutical therapies. This insight led him to research alternative and complementary options, including medical cannabis. Bachman’s vision for LeafLine Labs is to bring safe, consistent and high-quality medical cannabis to the people of Minnesota. It’s a new model for health care, one grown from the roots of early medicine, that brings patients and caregivers together in the same space to facilitate more natural, compassionate interactions. A Minnesota native, Bachman completed his emergency medicine residency at Hennepin County Medical Center, received his medical degree from Georgetown University School of Medicine and earned an undergraduate degree in biology from Amherst College.
Gary Starr, MD
Chief Medical Officer, Co-Founder
Dr. Gary Starr brings a deep understanding of medical cannabis solutions and nearly two decades of clinical experience to LeafLine Labs. He also currently serves in a variety of leadership roles in the American College of Emergency Physicians. This broad experience – guiding medical policy and working with national and state legislators – provides a unique perspective, which has allowed Starr to lead effective change despite the challenges posed by the intersection of modern medicine, business and politics. Dr. Starr founded LeafLine Labs with his friend and colleague, Dr. Andrew Bachman, after researching better ways to care for many of the suffering patients they treated. Starr completed his emergency medicine residency at The University of Chicago and his Family Medicine Residency at Saint Louis University. He received his medical degree from The University of Cincinnati College of Medicine. He is a veteran of the United States Air Force where he served as a flight surgeon under Special Operations Command.
Chief Financial Officer and Chief Operating Officer
Creativity is central to Colin Kelley’s leadership at LeafLine Labs. As Chief Financial Officer and Chief Operating Officer, Kelley is creating and guiding a company that he envisions will become a model for the nation for bringing the evidence-based benefits of medical cannabis to patients and families in need. Kelley attended Bryant University in Rhode Island where he majored in management and finance and earned minors in psychology and English. His career includes positions at Dun & Bradstreet, Investors Bank & Trust and Wind River Capital Management. He also consulted for a medical imaging firm affiliated with Massachusetts General Hospital. Committed to a holistic approach to healthy living, Kelley is a certified instructor for vinyasa yoga.
Rachel Loeber, PhD
VP of Laboratory Operations
Dr. Rachel Loeber is an analytical chemist by training with extensive experience in chromatography and mass spectrometry. She earned her B.S. from the University of Wisconsin – River Falls with a dual major in Biochemistry and Biotechnology. This was followed by a Ph.D. in Medicinal Chemistry in the laboratory of Dr. Natalia Tretyakova at the University of Minnesota – Twin Cities. At LeafLine Labs, Dr. Loeber oversees both production and R&D activities involving cannabis extraction, medical cannabis formulation, analytical testing, and regulatory compliance. She has drawn from her previous industrial laboratory experience to bring scientific rigor and good laboratory practices to LeafLine Labs, differentiating them as a leader in the ever-evolving medical cannabis industry. Dr. Loeber enjoys networking with other scientists and is an active member of numerous scientific and cannabis-specific interest groups.
Staci Prise, PharmD, RPh
Director of Pharmacy
With a passion for patient care and a background in analytical development, Staci Prise leads the pharmacy team, overseeing pharmacists across LeafLine’s dispersed geographic sites. Prise earned her B.S. in Chemistry from the University of Minnesota – Twin Cities and her Pharm.D. from Concordia University Wisconsin School of Pharmacy. She worked as an analytical chemist in pharmaceutical product development as well as in retail pharmacy for Walgreens. Her background in both development and clinical pharmacy give Prise a foundation to drive individualized, condition-specific care to each of our patients.